Well I am not a expert on patents but one would think that if PPL -1 has been patented by Novartis then there would need to be some sort of agreement between them and PAA
Ann: Further Update on New Anti-Cancer Drug PPL-1 in Human Trial, page-49
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $87.51M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.5¢ | $72.54K | 405.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 264963 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 66509 | 5 |
View Market Depth
| Last trade - 14.58pm 29/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |